Furthermore, simultaneous knockdown of IFIT3 and UBE2O did not significantly affect the subcutaneous tumor volume compared with that in the control group; however, knockdown of UBE2O alone resulted in a significant reduction in tumor volume (Fig. 6F) (p < 0.001). The gene discussed is IFIT3; the disease is neoplasm.